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Treatment of intact human polymorphonuclear neutrophils (PMN) with low concentrations of phorbol myristate acetate (PMA, l-10 @ml) 
induced paf-acether (paf) and lyso paf formation, arachidonate release, and simultaneous inhibition of CoA-independent lyso paf : transacylase 
as assayed in a cell-free system. Inhibition of [‘Hllyso paf reacylation was also observed when it was exogenously added to the PMA-treated intact 
PMN. When higher concentrations of PMA (40-100 ng/ml) were used. paf biosynthesis was severely impaired and the level ofthe CoA-independent 
transacylase activity returned to basal level. Since lyso paf appears to be the substrate for PMA-activated paf formation (remodeling pathway), 
we showed that [‘4C]acetate was incorporated into the paf molecule. By contrast, labeling with [“HIcholine was not appropriate in this model. The 
presented results are against the involvement of a de novo route in paf synthesis initiated by PMA and open a new possibility of an important 
role for the CoA-independent transacylase in controling the level of lyso paf availability for paf formation. 
Polymorphonuclear neutrophil (human): Paf-acerher; CoA-independent transacylase 
1. INTRODUCTION 
In human polymorphonuclear neutrophils (PMN) 
stimulated by a variety of agents, paf-acether (paf) is 
mainly synthesized via the remodeling pathway, i.e. 
deacylation/acetylation of pre-existing membrane phos- 
pholipid class of alkylacylglycerophosphocholine 
(AAGPC) (reviewed in [l]). However, conflicting results 
concerning the phorbol ester-activated de novo route 
for paf biosynthesis in PMN have also been published 
[2]. Two major factors limiting paf biosynthesis via the 
remodeling pathway were discovered: the level of acti- 
vation of lyso paf (I-alkyl-GPC) : acetyl-CoA acetyl- 
transferase (EC 2.3.1.67) and the avaibility of lyso paf 
[3-71. The latter might be formed either directly by 
phospholipase Az action on AAGPC or by a CoA-inde- 
pendent transacylase inducing a transfer of arachidonic 
acid (AA) from arachidonyl-containing AAGPC [S]. In 
this context, phospholipase A, might generate lyso-deri- 
vative acceptor and thus participate indirectly in the 
deacylation of paf precursor. Under the conditions that 
are optimal for acetyltransferase activation, either the 
supply of exogenous lyso paf [6] or coincubation with 
thrombin-activuted platelets, a source of abundant lyso 
paf [9], enhanced paf biosynthesis by activated PMN. 
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When analyzing the time course of lyso paf formation 
in stimulated PMN we noticed that free lyso paf was 
only transiently present in these cells [6]. In addition, 
only concentrations of phorbol myristate acetate 
(PMA) between 1 and 10 ng/ml promoted lyso paf accu- 
mulation above the basal level [7]. In this report we 
address the question of the involvement of CoA-inde- 
pendent transacylase in the modulation of lyso paf 
availability by PMA. We also present new evidence 
suggesting that the phorbol esters activate the re- 
modeling pathway rather than de novo one. 
2. MATERIALS AND METHODS 
Reagents were purchased as indicated. 4-y-phorbol- 12.myristate- 
I3-acetate (PMA). ionophore A23187 (IO; both prepared as 1 or IO 
mgml stock solutions in dimethylsulfoxyde were kept at -20°C). fatty 
acid-free bovine serum albumin (BSA). creatine phosphate. creatine 
phosphokinasc: Sigma Chemical Co., St. Louis. MC: USA. Aspcgic: 
Laboratoire Egic. Amilly. France. Lipasc from Rlrimprrs urrlkus: 
Bochringcr, Mannheim, Germany. Pal’Cl8:O : Novabiochem, Cltry 
en Vcxin. France. [‘H]lyso paf (I-O-[“Hloctadccyl-GPC, I63 Gil 
mmol). [‘Qtcetatc (60 mCi/mmol), [‘HIcholine (85 Ci/mmol) [‘H]ara- 
chidonic acid (2.9 Ci/mmol), [‘Hjpaf (I-O-[‘Hloctadecyl-2-acctyl- 
GPC. 128 Ci/mmol). [‘H]phosphaditylcholinc (62 Ci/mmol): Amcr- 
sham 1n1.. Amcrsham. UK. 
Venous blood from healthy donors was collec~cd and ncutrophils 
wcrc prcparcd as in (71. The cell pellet was rcsuspcndcd in HEPES 
bulTcr (pH 7.4) containing (mM) : KCI 2.6, NnCI 137, CaCI, 1.3, 
MgCl: I ,O, ~IUCOSC 5.6, HEPES 4.2. and O.?S% BSA. Preparations 
wcrs Y8% PMN-positive (May Gr~lilwald.Gicriisa). Cells ( IVhnl) wcrc 
stimuiatcd for GO min at 37°C with PMA (I IO 100 @ml) or 15 mitt 
with lo (2 /r&ml), When total formation of paf and lysv paf \vcrc to 
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be assessed, the reaction was stopped by the addition of 4 vols. of 
ethanol and processed as in [6]. Paf and lyso paf. transformed into paf 
by chemical acetylation. were quantitated by aggregation of washed 
rabbit platelets dnd results expressed in pmol/lOb PMN. as calculated 
over a calibration curve with Cl&O paf [IO]. To assess the effect of 
PMA treatment on the CoA-independent transacyiase. the stimulation 
of PMN was stopped by washing with NaCl I50 mM (4”C, 400 x g 
for 5 min). The cell pellets were resuspended in 0.2 ml of HEPES- 
EDTA (1 mM. pH 6.5) buffer, sonicated 15 s (Branson Sonic Power 
Co., Danbury, CT: microtype. position 3) and stored at -80°C until 
assay. 
To assess the effect of PMA treatment on the lyso paf reacylation 
by intact PMN. cells were washed with NaCl as above. resuspended 
in I ml of HEPES-BSA containing [‘H]lyso paf (0.5 &i) and reincu- 
bated for I5 min at 37°C. The reaction was stopped by adding 3 ml 
of chloroform/methanol (1:2, v/v) to achieve phase separation [I I]. 
The organic phase was brought to dryness under an air flow at 40°C 
and the resulting residue was further analyzed by liquid chromato- 
graphy (microporasil column. Waters, Milford. MA) using dichloro- 
methane/methanol/water (60:50:5. v/v) as mobile phase at a flow rate 
of I ml/min [I 21. pH]phosphatidylcholine(S min). [‘H]paf (16 min) and 
pH]lyso paf (24 min) served as standards (retention time). 
2.2. ltrcorpornlion of P’HJAA. [‘JCJ~~~c’~~tre crnd /3H]cimlitw 
by PMN 
PMN (3 x 1 O’/ml) were preincubarcd for IO min at 37°C in HEPES- 
BSA containing 3OpCi of [“H]AA. The cells were centrifuged (20°C). 
then washed twice with 45 ml of HEPES-BSA buffer devoid of Ca” 
and Mgr’. The cell pellet was resuspended in HEPES-BSA buffer. 
PMN were incubated at 37°C with detined concentrations of PMA or 
vehicle. the reaction was stopped by ccntrifugation (4°C) and the level 
of [“H]AA release was assessed in the supernatants. 
PMN (2 x IO’/2 ml) wcrc preincubated IO min at 37°C with 2OpCi 
[“Clacetate prior to stimulation as described above. Cells were also 
preincubated 1 or 2 h at 37°C with 20&i [“HIcholine alone. or40pCi 
[“‘C]acetate was added IO min before stimulation. All reactions were 
stopped by adding 6 ml of chloroform/methanol (1:2! v/v) as in [I I]. 
Labeled phospholipids were treated overnight by lipase A, [13], reex- 
tracted and separated on TLC using chloroform/methanol/watcr/ace- 
tic acid (50:25:4.5:4.5. v/v) as mobile phase. 
CoA-independent transacylase was assayed as in [I41 using Tyrode 
buffer (pH G.5) supplcmcnted with 0.16,~M [!H]lyso paf (O.OS,Ki) and 
ccl1 lysate prepared as described above. Incubations were carried on 
for IO min at 37°C. samples were extracted [I I] and analyzed by TLC 
as above. 
3. RESULTS AND DISCUSSION 
PMN were stimulated for 60 min with graded concen- 
trations of PMA. As we have shown earlier [7]. lyso paf 
and paf formation increased with PMA concentrations 
between 1 and 10 ng/ml, whereas at higher concentra- 
tions lyso paf remained at the basal level (Fig. 1A). 
Since the lyso paf formed during stimulation is not only 
the substrate for acetyltransferasc, but also might bc 
acylated back into AAGPC by the CoA-independent : 
lyso paf transacylasc [15], WC measured activity of this 
enzyme (Fig. 1 B). WC observed that the rate of transncy- 
lation, when assayed in a cell-free system supplemented 
with [‘H]lyso paf. was modulated by the treatment of 
intact the PMN by PMA. The enzyme activity was dc- 
crcascd by 15 to 38% in cells treated with low conccntra- 
tions of PMA (1 to 25 ng/ml) and almost returned to the 
PMA (nglml) 
PMA (nglml) 
Fig. I. Paf biosynthesis and activity of the CoA-independent transacy- 
last. A. Paf (0) and lyso paf (0) formation by PMA-treated (GO min 
at 37°C) PMN. Results in pmol/lOb cells arc means -t SE of 3 to 5 
expcrimcnts. except at 30 and 40 @ml PMA (a=2). B. Activity of 
[“H]lyso paf : CoA-independent transacylasc in sonicates of PMA- 
treated (60 min at 37°C) PMN. Results are the percentages of trans- 
acylase activity as compared to untrcatcd PMN and are means of 2 
separate experiments, where 100% of activity was 6.6 and 8.8 pmoll 
min per IOh cells. Bars: reacylation of rH]lyso paf into AAGPC by 
PMA-trcatcd intact PIMN. PMN were treated with PMA (60 min at 
37°C). washed and rcincubated with [‘Hllyso paf for 15 min. Results 
as pcrccntage of the total radioactivity (259,738 ?I 8.51 I dpm, SE of 
8 determinations) recovered after liquid chromatography arc means 
of 4 separate cxpcriments. When I00 ng/ml PMA was used 29 f 7% 
of [‘Hllyso paf was rcacylated into AAGPC. 
basal level when higher concentrations were used. This 
biphasic effect of PMA might be due to selective activa- 
tion of protein kinase C isoforms as shown in human 
platelets [16] and with purified rat brain isozymes [17]. 
A modulation of CoA-independent transacylasc by pro- 
tein kinase C activators has also been found in rat pla- 
tclets [I 81. Jn the next set of experiments, PMN wcrc 
triggcrcd with PMA at IO,40 and 100 ng/ml, for GO min 
at 37°C. After washing, the intact cells were rcincubatcd 
for 15 min at 37°C with [3H]lyso paf (Fig. IB). The 
rcacylation rate. ic. the pcrcentugc of AAGPC formed 
with rcspcct to the total radio;lctivity recovcrcd after 
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Table I 
Labeling of paf and its precursors with [%]acetate and [‘HIcholine 
and paf quantitation. 
Stimulation 
Lyso paf 
[‘HIcholine 
Control 
(2 $ml) (20 ng/m~)“~OO n&ml) 
76.Ok22.5 58.5?9.1 265.3+6.7 301.8+106.1 
AAGPC 80.4t13.4 146.9241.3 674.0k223.2 456.1+106.1 
[‘HIcholine 
paf 
[‘H]choline” ND 11.2b -zI.Ob -=l.Ob 
[14C]acetate ND 31.324.7 8.3kZ.l 6.752.1 
Bioassay ND 548? 122 66e12 46?10 
Specific activity NA 70?30 128+34 147+16 
PMN (2 x lo’/2 ml) were preincubated at 37°C for 1 or 2 h with 20 
PCi [‘HIcholine, next 40 @Zi [“‘Clacetate was added for additional 10 
min and cells were stimulated with 10 for I5 min or PMA for 60 min. 
After extraction, phospholipids were analyzed on TLC or TLC and 
subsequent li:,uid chromatography’. Results of [‘HIcholine and 
[‘%]acetate incorporation are expressed in dpm x 10e3, bioassay in 
pmol and specific activity of [14C]paf in dpm/pmol. They are 
means+SEM of 3 or 4 independent experiments. ND, not detected; 
NA, not applicable; one positive result out of 4 independent experi- 
mentsb. 
liquid chromatography separation, was lower in cells 
stimulated with 10 ndml PMA than in those exposed 
to 40 and 100 n@ml. 
Since the modulation of the Co&independent trans- 
acylase might govern availability of lyso paf for paf syn- 
thesis, it was important to show that labeled acetate was 
incorporated into paf. We showed that both 10 and 
PMA induced incorporation of the label into paf (Table 
I). In addition, mass of paf measured by the bioassay 
revealed that the specific activities of paf formed were 
not substantially different in IO- versus PMA-stimu- 
lated cells. In contrast, both agonists promoted only 
weak incorporation of labeled choline into paf (one 
positive experiment out of 4) that was only detectable 
after liquid chromatography of TLC eluates. We found 
that labeled choline was mainly incorporated, after li- 
pase A, hydrolysis of the sn-I acyl bond, into lyso paf 
and AAGPC (Table I). Jo-stimulation slightly enhanced 
AAGPC labelling without any change in lyso paf, whe- 
reas PMA induced a several-fold increase in [3H]choline 
incorporation into both. Fractions corresponding to 
lyso paf did not contain platelet aggregating activity. 
but when chemically acetylated, they became indistin- 
guishable from our paf standard (data not shown). Thus 
the radioactivity comigrating with the lyso paf standard 
did not contain paf, which could be masked by such a 
substantial incorporation of [“HIcholine into lyso paf. 
The low amount of paf formed, together with the high 
[“HIcholine incorporation into paf precursors, might ac- 
count for the discrepancies between our own and the 
former study (21. 
140 
Since labeled acetate but not choline is incorporated 
into paf, the remodeling pathway is most probably op- 
erational in paf biosynthesis initiated by PMA. We also 
checked that PMN prelabeled with arachidonate re- 
leased this fatty acid after incubation with 10 @ml 
PMA: at 30 min, 15.7 2 5.2% net release, n=3; at 120 
min 24.4 f 3.6%, n=5. This time-course is similar to that 
of lyso paf and paf biosynthesis [7] and is consistent 
with a close relationship between arachidonate release 
and paf biosynthesis [19]. The latter finding, together 
with our earlier description of acetyltransferase activa- 
tion in PMN stimulated by PMA [7], indicate that paf 
is formed by these cells rather as a result of activation 
of the remodeling pathway than the de novo route [2]. 
In the former pathway, the CoA-independent transacy- 
lase might directly control lyso paf supply [8] or modu- 
late lyso paf availability by changing the rate of its 
reacylation with long chain fatty acids. 
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